Merck KGaA (MKGAF)

Market Cap	56.93B
Revenue (ttm)	23.04B
Net Income (ttm)	3.05B
Shares Out	n/a
EPS (ttm)	7.00
PE Ratio	18.69
Forward PE	12.87
Dividend	2.50 (1.90%)
Ex-Dividend Date	Apr 28, 2025

Volume	515
Average Volume	391
Open	128.97
Previous Close	129.80
Day's Range	128.97 - 134.28
52-Week Range	118.05 - 200.56
Beta	0.64
RSI	49.15
Earnings Date	May 15, 2025

About Merck KGaA

Merck KGaA operates as a science and technology company in Germany. It operates through Life Science, Healthcare, and Electronics segments. The company’s Life Science segment offers tools, chemicals, and equipment for academic labs, biotech, and pharmaceutical manufacturers, as well as industrial sector. This segment provides drug manufacturers with process development expertise and technologies, such as continuous bioprocessing; testing kits and services; reagents and services; testing solutions that analyze air, water, and soil; and testing a...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1668
• Employees: 59,020
• Stock Exchange: OTCMKTS
• Ticker Symbol: MKGAF

Financial Performance

In 2024, Merck KGaA's revenue was 21.16 billion, an increase of 0.78% compared to the previous year's 20.99 billion. Earnings were 2.78 billion, a decrease of -1.66%.

Financial numbers in EUR